Advancing early diagnosis of inflammatory bowel disease: A call for enhanced efforts

World J Gastroenterol. 2024 Dec 28;30(48):5191-5193. doi: 10.3748/wjg.v30.i48.5191.

Abstract

The diagnosis of inflammatory bowel disease (IBD) is complicated by its nonspecific clinical presentation and the limited accuracy of existing biomarker tests, frequently resulting in significant delays from the time of symptom onset to the achievement of a definitive diagnosis. Thus, improving the early identification of IBD remains a crucial focus for gastroenterologists. Blüthner et al innovatively utilized medical data from German IBD patients to investigate risk factors contributing to these diagnostic delays. However, certain methodological limitations in the study have impacted data extraction and interpretation, underscoring the need for more comprehensive analyses to validate these findings.

Keywords: Crohn’s disease; Diagnostic delay; Early identification; Inflammatory bowel disease; Ulcerative colitis.

Publication types

  • Editorial

MeSH terms

  • Biomarkers* / analysis
  • Biomarkers* / blood
  • Delayed Diagnosis / prevention & control
  • Early Diagnosis*
  • Germany / epidemiology
  • Humans
  • Inflammatory Bowel Diseases* / diagnosis
  • Inflammatory Bowel Diseases* / therapy
  • Risk Factors

Substances

  • Biomarkers